Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.720
+0.250 (17.01%)
At close: Aug 13, 2025, 4:00 PM
1.710
-0.010 (-0.58%)
After-hours: Aug 13, 2025, 7:57 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $5.92 million as of August 13, 2025. Its market cap has decreased by -19.50% in one year.
Market Cap
5.92M
Enterprise Value
2.95M
1-Year Change
-19.50%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $5.92M, a decrease of -89.89%. That is a compound annual growth rate of -45.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 5.06M | -65.26% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 591.63B |
| Johnson & Johnson | 419.80B |
| AbbVie | 355.73B |
| UnitedHealth Group | 245.18B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.87B |
| Novo Nordisk | 223.00B |